Life Sciences: What's new in France?
February 28, 2020
Read more about the recent developments in the life sciences sector in France.
Content:
- Plavix Case: Sanofi Escapes Liability in Damages Claim Launched by the French State
- Consequences of France’s PACTE law on Statute of Limitations on Patent Nullity Actions
- The 2020 Social Security Financing Act Provides Legal Basis for the French Medical Cannabis Pilot Programme
- The French National Authority for Health Proposes a Novel Approach to Assess Advanced Therapies
- French regulation against shortages of medicinal products reinforced
- The Paris Court of Appeal Upholds the French Competition Authority’s Decision Sanctioning Janssen-Cilag’s Intervention Before the French Health Regulator
- Obligation to State Reasons in a Decision Conditioning the Reimbursement of Medicines
Related Professionals
